Total Payments
$561.02
2024 Payments
$172.79
Companies
5
Transactions
19
Medicare Patients
2,125
Medicare Billing
$91,668
Payment Breakdown by Category
Food & Beverage$561.02 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $561.02 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $221.29 | 2 | $0 (2024) |
| Allergan, Inc. | $152.99 | 8 | $0 (2020) |
| AbbVie Inc. | $136.96 | 7 | $0 (2021) |
| Corcept Therapeutics | $24.95 | 1 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $24.83 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $172.79 | 3 | AstraZeneca Pharmaceuticals LP ($123.01) |
| 2021 | $136.96 | 7 | AbbVie Inc. ($136.96) |
| 2020 | $152.99 | 8 | Allergan, Inc. ($152.99) |
| 2018 | $98.28 | 1 | AstraZeneca Pharmaceuticals LP ($98.28) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $123.01 | General |
| Category: Respiratory | ||||||
| 05/04/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Endocrinology | ||||||
| 05/04/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 07/01/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.20 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: NEUROSCIENCE | ||||||
| 02/11/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: NEUROSCIENCE | ||||||
| 01/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/28/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $98.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 490 | 496 | $68,654 | $19,756 |
| 2022 | 12 | 522 | 528 | $79,180 | $23,103 |
| 2021 | 14 | 721 | 740 | $94,426 | $35,769 |
| 2020 | 12 | 392 | 413 | $45,934 | $13,040 |
Total Patients
2,125
Total Services
2,177
Medicare Billing
$91,668
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 92 | $18,860 | $5,628 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 68 | $20,808 | $5,456 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $7,192 | $2,155 | 30.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 38 | 38 | $3,298 | $1,967 | 59.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $5,479 | $1,497 | 27.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 45 | 45 | $4,617 | $934.42 | 20.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 56 | 58 | $754.00 | $478.80 | 63.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 15 | $1,995 | $444.30 | 22.3% |
| 80047 | Blood test, basic group of blood chemicals (calcium, ionized) | Office | 2023 | 28 | 29 | $1,601 | $390.34 | 24.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 45 | 45 | $1,665 | $334.84 | 20.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 20 | 20 | $1,061 | $324.00 | 30.5% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 27 | 27 | $999.00 | $106.38 | 10.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 13 | $325.00 | $40.92 | 12.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 96 | $29,376 | $8,331 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 95 | $19,475 | $5,435 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $7,956 | $3,052 | 38.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $5,945 | $2,212 | 37.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 39 | 39 | $2,925 | $1,191 | 40.7% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 52 | 52 | $5,336 | $1,078 | 20.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 18 | $2,394 | $573.52 | 24.0% |
| 80047 | Blood test, basic group of blood chemicals (calcium, ionized) | Office | 2022 | 28 | 28 | $1,512 | $366.87 | 24.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 39 | 39 | $1,443 | $299.43 | 20.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 16 | 16 | $784.00 | $260.82 | 33.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 54 | 54 | $702.00 | $160.08 | 22.8% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 35 | 36 | $1,332 | $143.00 | 10.7% |
About Dr. Michael Thompson, MD
Dr. Michael Thompson, MD is a General Practice healthcare provider based in Chesapeake, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306885041.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Thompson, MD has received a total of $561.02 in payments from pharmaceutical and medical device companies, with $172.79 received in 2024. These payments were reported across 19 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($561.02).
As a Medicare-enrolled provider, Thompson has provided services to 2,125 Medicare beneficiaries, totaling 2,177 services with total Medicare billing of $91,668. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Other Specialties Family Medicine
- Location Chesapeake, VA
- Active Since 06/06/2006
- Last Updated 03/30/2022
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1306885041
Products in Payments
- UBRELVY (Drug) $260.81
- AIRSUPRA (Drug) $123.01
- FARXIGA (Drug) $98.28
- BOTOX (Biological) $29.14
- Korlym (Drug) $24.95
- RECORLEV (Drug) $24.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Chesapeake
Danielle Spinden, Dmd, DMD
General Practice — Payments: $6,537
General Practice $6,537
Dr. John Duerden, M.d, M.D
General Practice — Payments: $5,296
General Practice $5,296
Tanya Brown, D.m.d, D.M.D
General Practice — Payments: $3,525
General Practice $3,525
Dr. Bennett Thomas, Dds, DDS
General Practice — Payments: $3,070
General Practice $3,070
Stephen Asam, D.d.s, D.D.S
General Practice — Payments: $2,858
General Practice $2,858
Dr. Ryan Shuck, Dds, DDS
General Practice — Payments: $2,466
General Practice $2,466